Skip to content

Psychosocial Factors and Central Sensitization in Chronic Pelvic Pain

Psychosocial Factors and Central Sensitization in Chronic Pelvic Pain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02856334
Enrollment
100
Registered
2016-08-04
Start date
2016-01-31
Completion date
Unknown
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Pain, Pudendal Neuropathy, Vulvodynia

Keywords

chronic pelvic pain, vulvodynia, pelvic pain, psychosocial factors, central sensitization

Brief summary

The purpose of this study is to determine if the psychosocial factors in women with chronic pelvic pain are predisposing, precipitant or maintenance factors, and relate these factors with central sensitization and dysfunctional pain.

Detailed description

This study pretends clarify the psychosocial factors presents in women with chronic pelvic pain, and determine if this factors are predisposing, precipitant or of maintenance, through an interview and a series of validated questionnaires. In addition, these findings will be related to the presence of central sensitization, as measured by quantitative sensory testing.

Interventions

None listed

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 55 years * Chronic pelvic pain diagnosis, defined as persistent pain in pelvis related structures * Pain duration ≥6 months * Average pain intensity ≥3/10 in NRS during the previous week * To understand the objectives of the study

Exclusion criteria

* Suspicion or knowledge of current organic pathology that requires medical or surgical treatment * Pain as a consequence of surgery known * Pending litigation or financial compensation * Psychiatric disorders: major depression, bipolar syndrome, etc .. * Cognitive difficulties * Not sign the informed consent

Design outcomes

Primary

MeasureTime frame
Interview on psychosocial factorsDay 1

Secondary

MeasureTime frameDescription
Multidimensional Pain Inventory (MPI) - Interference ScaleDay 1
Oswestry Disability IndexDay 1
Hospital Anxiety and Depression Scale (HADS)Day 1
Pain Catastrophizing ScaleDay 1
Coping Strategies Questionnaire (CSQ)Day 1
Tampa Scale for Kinesiophobia (TSK) -11Day 1
Survey of Pain Attitudes-35 (SOPA-35)Day 1
Female Sexual Function Index (FSFI)Day 1
Patient Specific Functional Scale (PSFS)Day 1
Patient Health Questionnaire (PHQ)Day 1
Quantitative Sensory Testing-Pain Pressure Threshold (PPT)Day 2in kg/s
Quantitative Sensory Testing-Temporal Summation (TS)Day 2in kg/s
Quantitative Sensory Testing-Conditioned Pain Modulation (CPM)Day 2in kg/s
Neurophysiology of pain questionnaire (NPQ)Day 1

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026